<DOC>
	<DOCNO>NCT02558439</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy single injection CNTX-4975 subject chronic , moderate severe osteoarthritis knee pain .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy CNTX-4975 Subjects With Chronic , Moderate Severe Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Radiography knee posterioranterior , fixed flexion view take Screening period . The index knee must show evidence chronic OA . Moderate severe pain index knee associate OA must stable minimum 2 month prior Screening , assess Investigator . A specified mean pain score index knee 7 day prior dose , base question A1 Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC A1 ) . Specified baseline screening score WOMAC A1 Body Mass Index ≤ 45 kg/m2 . Subjects must therapeutic failure ( relief , inadequate relief ) , and/or AEs result stop treatment , and/or contraindication standard care appropriate severity index knee OA pain experience . Joint replacement surgery index knee time , open surgery index knee past 12 month . Prior arthroscopic surgery index knee within 3 month Screening . Any painful condition index knee due joint disease OA . Mild pain nonindex knee walking . Other chronic pain anywhere body require use analgesic medication . Secondary OA index knee due acute traumatic injury . Significant current past instability ( e.g. , cruciate ligament tear rupture previous repair ) misalignment ( &gt; 10 degree varus valgus ) index knee Has use topical capsaicin index knee within 90 day Screening . Corticosteroid injection index knee within 90 day Screening . Received IA viscosupplementation ( e.g. , Synvisc® , Hyalgan® ) within 90 day Screening . Prior participation ALGRX 4975 CNTX4975 study . Has follow characteristic : 1. active historic substance use disorder within previous year define Diagnostic Statistical Manual Mental Health Disorders , fifth edition , 2. test positive upon urine drug screen substance abuse . Has moderate severe depression anxiety .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>